目的 探讨红花黄色素(safflower yellow, SY)对冈田酸(okadaic acid, OA)诱导SH-SY 5Y细胞高磷酸化水平的调节作用及可能机制。方法 SH-SY 5Y细胞给予红花黄色素(0.01、0.1、1 g·L-1)处理,4 h后给予冈田酸 80 nmol·L-1处理48 h,利用MTT法测定红花黄色素对冈田酸损伤的SH-SY 5Y细胞存活率的影响。Hoechst 33342染色法观察红花黄色素对冈田酸诱导的SH-SY 5Y细胞损伤中凋亡的影响。Western blot检测红花黄色素对冈田酸诱导的SH-SY 5Y细胞中p-tau(T205、S199)、总GSK-3β 和PP2A的表达。结果 红花黄色素可明显增加冈田酸损伤的SH-SY 5Y细胞的生存率,Hoechst 33342染色显示红花黄色素可显著减少冈田酸损伤的SH-SY 5Y细胞的凋亡细胞个数。Western blot检测结果显示,p-tau(T205、S199)位点tau蛋白含量增加,红花黄色素能够显著降低tau蛋白的含量, 红花黄色素能够增加PP2A的表达和降低GSK-3β表达。结论 红花黄色素对冈田酸损伤的SH-SY 5Y细胞具有一定保护作用,并可能通过调节tau蛋白上游激酶和磷酸酶的蛋白表达而降低tau蛋白磷酸化水平。
Abstract
OBJECTIVE To investigate the regulating effects and its possible mechanism of safflower yellow (SY) on tau protein hyperphosphorylation in SH-SY 5Y cell induced by okadaic acid (OA). METHODS Cell viability was measured by MTT colorimetric method. The cell apoptosis was determined with Hoechst 33342 after SH-SY 5Y cell were treated with SY. To determined the phosphorylated tau protein of p-tau(T205), p-tau(S199) sites, and total GSK-3β, PP2A in SH-SY 5Y cell were determined using Western blotting. RESULTS SY significantly increased survival rates of SH-SY5Y cell damaged by OA. Hoechst 33342 showed that SY decreased the apoptosis of SH-SY5Y cells. Western blotting analysis showed that tau protein content was increased compared to control group at p-tau (T205), p-tau (S199) sites. However, SY treatment significantly reduced tau protein content at p-tau (T205) and p-tau (S199) sites. PP2A content was significantly suppressed by OA, significantly increased by SY, GSK-3β content was significantly increased by OA and significantly decreased by SY. CONCLUSION These results suggest that safflower yellow may have neuroprotective effect on OA-induced SH-SY 5Y cells injury, which may be associated with tau hyperphosphorylation at the enzyme level by activation of tau kinases or by a decline in the activities of tau phosphatases.
关键词
红花黄色素 /
tau蛋白磷酸化 /
蛋白激酶 /
磷酸酶
{{custom_keyword}} /
Key words
safflower yellow /
tau hyperphosphorylation /
kinase /
phosphatase
{{custom_keyword}} /
中图分类号:
R965
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] BOUTAJANGOUT A, SIGURDSSON E M,KRISHNAMURTHY P K. Tau as a therapeutic target for Alzheimer′s disease [J]. Curr Alzheimer Res, 2011, 8(6):666-677.
[2] IQBAL K, GONG C X, LIU F. Microtubule-associated protein tau as a therapeutic target in Alzheimer′s disease [J]. Expert Opin Ther Targets, 2014, 18(3):307-318.
[3] IQBAL K, ALONSO A C, CHEN S, et al. Tau pathology in Alzheimer disease and other tauopathies [J]. Biochim Biophys Acta, 2005, 1739(2-3):198-210.
[4] HASHIGUCHI M, HASHIGUCHI T. Kinase-kinase interaction and modulation of tau phosphorylation [J]. Int Rev Cell Mol Biol, 2013, 300:121-160.
[5] EKINCI F J, ORTIZ D, SHEA T B. Okadaic acid mediates tau phosphorylation via sustained activation of the L-voltage-sensitive calcium channel [J]. Brain Res Mol Brain Res, 2003, 117(2):145-151.
[6] XU H, MA Q, WANG Z X, et al. Effects of safflower yellow on learning and memory impairments of vascular dementia in rats[J]. Chin Pharm J (中国药学杂志), 2014, 49(12):1032-1035.
[7] MA Q, XU H, RUAN Y Y, et al. Effects of safflower yellower on learning and memory disorders of dementia rats induced by Aβ1-42[J]. Pharmacol Clin Chin Mater Med (中药药理与临床), 2014, 30(5):64-66.
[8] HU Y L, WANG P L, ZHANG Y, et al. Effects of safflower yellow on learning and memory impairments of acopolamine-induced dementia in mice[J]. Chin J Gerontol(中国老年学杂志), 2012,32(19):4197-4198.
[9] ZHU Q Y, LI W, ZHANG L, et al. Effects of protein phosphatase inhibitor okadaic acid on phosphorylation of tau protein in human neuroblastoma SK-N-SH cells[J]. Chin J Cell Biol (细胞生物学杂志), 2006, 28(5):742-746.
[10] ZHU C Q, CAO X D. Effect of protein phosphatase-1 and inhibitor on Tau protein phosphorylation of NG108-4 cell[J]. Chin J Cell Biol (细胞生物学杂志), 2002, 24(2):115-117.
[11] EDELSTEIN J, ROCKWELL P. Okadaic acid induces Akt hyperphosphorylation and an oxidative stress-mediated cell death in serum starved SK-N-SH human neuroblastoma cells that are augmented by rapamycin[J]. Neurosci Lett, 2012, 531(2):74-79.
[12] ALONSO A C, MEDERLYOVA A, NOVAK M, et al. Promotion of hyperphosphorylation by frontotemporal dementia tau mutations[J]. J Biol Chem,2004,279(33):34873-34881.
[13] HU Z, MA R T,YU L J. Advances in research of okadaic acid[J]. Chin J Marine Drugs (中国海洋药物), 2001,20(1):46-50.
[14] MARTIN L, LATYPOVA X, WILSON C M, et al. Tau protein phosphatases in Alzheimer′s disease:The leading role of PP2A [J]. Ageing Res Rev, 2013, 12(1):39-49.
[15] WANG J Z, GRUNDKE-IQBAL I, IQBAL K. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration[J]. Eur J Neurosci, 2007,25(1):59-68.
[16] DOBLE B W, WOODGETT J R. GSK-3:Tricks of the trade for a multi-tasking kinase[J]. J Cell Sci, 2003, 116(7):1175-1186.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
国家自然科学基金资助项目(81360495);兵团博士基金资助项目(2101701)
{{custom_fund}}